Trident Lifeline

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0MKA01014
  • NSEID:
  • BSEID: 543616
INR
305.00
0.00 (0.00%)
BSENSE

Dec 05

BSE+NSE Vol: 600

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'25
Mar'24
Mar'23
Mar'22
Net Sales
86.96
44.63
31.69
21.77
Other Operating Income
0.00
0.00
0.00
0.00
Total Operating income
86.96
44.63
31.69
21.77
Raw Material Cost
43.05
21.12
12.19
10.09
Purchase of Finished goods
1.80
9.46
10.93
4.60
(Increase) / Decrease In Stocks
0.71
-1.23
-2.89
-0.46
Employee Cost
12.09
2.40
1.61
1.19
Power Cost
0.00
0.00
0.00
0.00
Manufacturing Expenses
-0.01
0.00
-0.01
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
Other Expenses
14.47
4.69
3.62
3.64
Total Expenditure (Excl Depreciation)
72.11
36.44
25.45
19.06
Operating Profit (PBDIT) excl Other Income
14.85
8.19
6.24
2.71
Other Income
8.23
2.08
1.16
0.60
Operating Profit (PBDIT)
23.08
10.27
7.40
3.31
Interest
3.99
0.60
0.47
0.13
Exceptional Items
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
19.09
9.67
6.93
3.18
Depreciation
5.49
0.97
0.36
0.20
Profit Before Tax
13.61
8.70
6.58
2.98
Tax
3.12
2.76
0.56
-0.96
Provisions and contingencies
0.00
0.00
0.00
0.00
Profit After Tax
10.49
5.94
6.01
3.95
Extraordinary Items
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
Net Profit
10.49
5.94
6.01
3.95
Share in Profit of Associates
0.00
0.00
0.00
0.00
Minority Interest
1.25
0.40
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
Consolidated Net Profit
11.75
6.34
6.01
3.95
Equity Capital
11.50
11.50
11.50
8.00
Face Value
10.0
10.0
10.0
10.0
Reserves
52.96
40.41
34.14
-3.22
Earnings per share (EPS)
10.22
5.51
5.23
4.94
Diluted Earnings per share
10.22
5.52
6.23
3.94
Operating Profit Margin (Excl OI)
17.08%
18.35%
19.69%
12.45%
Gross Profit Margin
21.95%
21.67%
21.87%
14.61%
PAT Margin
12.06%
13.31%
18.96%
18.14%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 94.85% vs 40.83% in Mar 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Mar 2025 is 85.33% vs 5.49% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 81.32% vs 31.25% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 565.00% vs 27.66% in Mar 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2025 has fallen from Mar 2024

Compare Annual Results Of Trident Lifeline With
Markets Mojo
Figures in Cr
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
86.96
155.71
-68.75
-44.15%
Other Operating Income
0.00
0.00
0.00
Total Operating income
86.96
155.71
-68.75
-44.15%
Raw Material Cost
43.05
109.29
-66.24
-60.61%
Purchase of Finished goods
1.80
14.33
-12.53
-87.44%
(Increase) / Decrease In Stocks
0.71
-6.02
6.73
111.79%
Employee Cost
12.09
7.43
4.66
62.72%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
-0.01
0.00
-0.01
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
14.47
14.26
0.21
1.47%
Total Expenditure (Excl Depreciation)
72.11
139.29
-67.18
-48.23%
Operating Profit (PBDIT) excl Other Income
14.85
16.42
-1.57
-9.56%
Other Income
8.23
2.12
6.11
288.21%
Operating Profit (PBDIT)
23.08
18.54
4.54
24.49%
Interest
3.99
3.67
0.32
8.72%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
19.09
14.87
4.22
28.38%
Depreciation
5.49
3.29
2.20
66.87%
Profit Before Tax
13.61
11.57
2.04
17.63%
Tax
3.12
3.73
-0.61
-16.35%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
10.49
7.84
2.65
33.80%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
10.49
7.84
2.65
33.80%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
1.25
0.30
0.95
316.67%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
11.75
8.15
3.60
44.17%
Equity Capital
11.50
15.58
-4.08
-26.19%
Face Value
10.00
10.00
0.00
Reserves
52.96
93.88
-40.92
-43.59%
Earnings per share (EPS)
10.22
5.23
4.99
95.41%
Diluted Earnings per share
10.22
5.60
4.62
82.50%
Operating Profit Margin (Excl OI)
17.08%
10.55%
0.00
6.53%
Gross Profit Margin
21.95%
9.55%
0.00
12.40%
PAT Margin
12.06%
5.04%
0.00
7.02%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 86.96 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 94.85% vs 40.83% in Mar 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 11.75 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 85.33% vs 5.49% in Mar 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 14.85 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 81.32% vs 31.25% in Mar 2024

Annual - Interest
Interest 3.99 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 565.00% vs 27.66% in Mar 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 17.08%
in Mar 2025

Figures in %
stock-summary

YoY Growth in year ended Mar 2025 has fallen from Mar 2024